Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


SOUTHWELL DAVID P Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 2,571 shares @ $50.0476, valued at $128.7k
Exercised 2,571 options to buy @ $18.01, valued at $46.3k
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.81, valued at $181k
01/09/2023 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 4,000 shares @ $0
Granted 10,000 options to buy @ $39.42, valued at $394.2k
07/27/2022 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $3.27, valued at $327k
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Bought 15,000 shares @ $3.6226, valued at $54.3k
Bought 10,000 shares @ $3.5482, valued at $35.5k
01/20/2022 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 275,000 options to buy @ $4.85, valued at $1.3M
01/11/2022 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 3,200 shares @ $0
Granted 12,000 options to buy @ $38.1, valued at $457.2k
12/27/2021 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Exercised 48,670 options to buy @ $1.97, valued at $95.9k
09/09/2021 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Bought 11,000 shares @ $8.7333, valued at $96.1k
07/15/2021 3 SOUTHWELL DAVID P (CEO) has filed a Form 3 on TScan Therapeutics, Inc.
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 1,650 shares @ $0
Granted 10,000 options to buy @ $66.49, valued at $664.9k
10/20/2020 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 14,300 shares @ $51.503, valued at $736.5k
Sold 700 shares @ $52.183, valued at $36.5k
Sold 11,500 shares @ $51.516, valued at $592.4k
Sold 500 shares @ $52.178, valued at $26.1k
Exercised 15,000 options to buy @ $10.85, valued at $162.8k
Exercised 12,000 options to buy @ $11.23, valued at $134.8k
06/18/2020 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 20,000 options to buy @ $19.9, valued at $398k
01/31/2020 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 1,650 shares @ $0
Granted 10,000 options to buy @ $51.16, valued at $511.6k
01/30/2019 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 30,000 options to buy @ $14.56, valued at $436.8k
01/24/2019 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $33.02, valued at $462.3k
12/14/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 38,768 shares @ $15.19, valued at $588.9k
12/10/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 52,809 shares @ $15.15, valued at $800.1k
Sold 4,923 shares @ $14.91, valued at $73.4k
Exercised 65,625 restricted stock units @ $0
06/06/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $11.54, valued at $70.1k
04/02/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 40,000 options to buy @ $18.75, valued at $750k
Exercised 21,875 restricted stock units @ $0
03/30/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 12,146 options to buy @ $14.25, valued at $173.1k
02/06/2018 3 SOUTHWELL DAVID P (Director) has filed a Form 3 on Spero Therapeutics, Inc.
01/05/2018 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $18.01, valued at $252.1k
01/24/2017 4 SOUTHWELL DAVID P (President and CEO) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
01/09/2017 4 SOUTHWELL DAVID P (President and CEO) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
01/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/24/2016 4 SOUTHWELL DAVID P (See Remarks) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
Txns: Granted 215,000 options to buy @ $7.56, valued at $1.6M
01/06/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/06/2015 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
06/26/2015 4 SOUTHWELL DAVID P (See Remarks) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP
Txns: Granted 150,000 options to buy @ $5.03, valued at $754.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy